Tracheal disorder

Summary

Tracheal disorder (MONDO:0002567) is a disease (an umbrella term covering 8 Mondo subtypes) and 3 clinical trials. A subtype of lower respiratory tract disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 8 Mondo subtypes
• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	tracheal disorder
Mondo ID	MONDO:0002567
MeSH	D014133
DOID	DOID:3225
NCIT	C35079
SNOMED CT	47125007
UMLS	C4025678
MedGen	892789
Anatomy (UBERON)	UBERON:0003126
Is cancer (heuristic)	no

Also known as: disease of trachea · disease or disorder of trachea · disorder of trachea · trachea disease · trachea disease or disorder · tracheal disorder

Disease family

This is a subtype of lower respiratory tract disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › lower respiratory tract disorder › tracheal disorder

Related subtypes (4): bronchial disorder, pleural disorder, lung disorder, tracheobronchitis

Subtypes (8): tracheal calcification, tracheal stenosis, chronic obstructive pulmonary disease, tracheitis, laryngotracheoesophageal cleft, isolated tracheo-esophageal fistula, congenital tracheomalacia, trachea neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06935110	Not specified	RECRUITING	Feasibility of Tracheobronchial Defect Reconstruction Using Allogenic Aortic Patch
NCT07240259	Not specified	ENROLLING_BY_INVITATION	Feasibility of Tracheobronchial Reconstruction Using Allogenic Aortic Patch in Children
NCT04850742	Not specified	UNKNOWN	Feasibility of Tracheobronchial Reconstruction Using Bioengineered Aortic Matrices